nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP2A6—lung cancer	0.281	0.719	CbGaD
Rosiglitazone—ALB—lung cancer	0.109	0.281	CbGaD
Rosiglitazone—ALB—Gefitinib—lung cancer	0.0339	0.0935	CbGbCtD
Rosiglitazone—SLCO1B1—Irinotecan—lung cancer	0.0331	0.0912	CbGbCtD
Rosiglitazone—CYP2C19—Gefitinib—lung cancer	0.022	0.0606	CbGbCtD
Rosiglitazone—CYP2C19—Teniposide—lung cancer	0.0213	0.0588	CbGbCtD
Rosiglitazone—ALB—Erlotinib—lung cancer	0.0201	0.0553	CbGbCtD
Rosiglitazone—PTGS1—Etoposide—lung cancer	0.0194	0.0536	CbGbCtD
Rosiglitazone—CYP2C9—Gefitinib—lung cancer	0.0183	0.0504	CbGbCtD
Rosiglitazone—ALB—Irinotecan—lung cancer	0.0181	0.0499	CbGbCtD
Rosiglitazone—CYP2C9—Teniposide—lung cancer	0.0177	0.0489	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—lung cancer	0.0175	0.0483	CbGbCtD
Rosiglitazone—CYP2D6—Gefitinib—lung cancer	0.0167	0.0461	CbGbCtD
Rosiglitazone—CYP2C8—Erlotinib—lung cancer	0.0155	0.0427	CbGbCtD
Rosiglitazone—CYP2C8—Paclitaxel—lung cancer	0.0142	0.0391	CbGbCtD
Rosiglitazone—CYP2D6—Vinorelbine—lung cancer	0.0129	0.0355	CbGbCtD
Rosiglitazone—CYP1A2—Erlotinib—lung cancer	0.012	0.0331	CbGbCtD
Rosiglitazone—CYP2C8—Etoposide—lung cancer	0.0112	0.0309	CbGbCtD
Rosiglitazone—CYP2C9—Paclitaxel—lung cancer	0.0099	0.0273	CbGbCtD
Rosiglitazone—CYP2D6—Erlotinib—lung cancer	0.00989	0.0273	CbGbCtD
Rosiglitazone—ALB—Methotrexate—lung cancer	0.00959	0.0264	CbGbCtD
Rosiglitazone—CYP1A2—Etoposide—lung cancer	0.00868	0.0239	CbGbCtD
Rosiglitazone—CYP2C9—Cisplatin—lung cancer	0.00796	0.0219	CbGbCtD
Rosiglitazone—CYP2D6—Vinblastine—lung cancer	0.00794	0.0219	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—lung cancer	0.00488	0.0134	CbGbCtD
Rosiglitazone—ACSL4—respiratory system—lung cancer	0.00178	0.0907	CbGeAlD
Rosiglitazone—ACSL4—bronchus—lung cancer	0.00146	0.0747	CbGeAlD
Rosiglitazone—SLCO1B1—mammary gland—lung cancer	0.00139	0.071	CbGeAlD
Rosiglitazone—ACSL4—trachea—lung cancer	0.00131	0.0671	CbGeAlD
Rosiglitazone—ACSL4—cardiac atrium—lung cancer	0.00123	0.063	CbGeAlD
Rosiglitazone—PPARG—mammary gland—lung cancer	0.0012	0.0613	CbGeAlD
Rosiglitazone—PPARG—Irinotecan—Topotecan—lung cancer	0.00119	0.33	CbGdCrCtD
Rosiglitazone—ALB—mammary gland—lung cancer	0.00112	0.0575	CbGeAlD
Rosiglitazone—ACSL4—bone marrow—lung cancer	0.00104	0.0532	CbGeAlD
Rosiglitazone—PPARG—Topotecan—Irinotecan—lung cancer	0.000991	0.274	CbGdCrCtD
Rosiglitazone—PPARG—Etoposide—Teniposide—lung cancer	0.000985	0.272	CbGdCrCtD
Rosiglitazone—ACSL4—lung—lung cancer	0.000943	0.0482	CbGeAlD
Rosiglitazone—PPARG—respiratory system—lung cancer	0.000799	0.0408	CbGeAlD
Rosiglitazone—CYP2C8—mammary gland—lung cancer	0.000791	0.0404	CbGeAlD
Rosiglitazone—CYP2C9—mammary gland—lung cancer	0.000702	0.0359	CbGeAlD
Rosiglitazone—PPARG—epithelium—lung cancer	0.000668	0.0341	CbGeAlD
Rosiglitazone—ACSL4—lymph node—lung cancer	0.000645	0.033	CbGeAlD
Rosiglitazone—CYP2A6—lung—lung cancer	0.000498	0.0255	CbGeAlD
Rosiglitazone—CYP1A2—respiratory system—lung cancer	0.000493	0.0252	CbGeAlD
Rosiglitazone—PPARG—bone marrow—lung cancer	0.000468	0.0239	CbGeAlD
Rosiglitazone—PPARG—Teniposide—Etoposide—lung cancer	0.000447	0.124	CbGdCrCtD
Rosiglitazone—PTGS1—respiratory system—lung cancer	0.000427	0.0218	CbGeAlD
Rosiglitazone—PPARG—lung—lung cancer	0.000424	0.0217	CbGeAlD
Rosiglitazone—PTGS1—epithelium—lung cancer	0.000357	0.0182	CbGeAlD
Rosiglitazone—PTGS1—trachea—lung cancer	0.000316	0.0161	CbGeAlD
Rosiglitazone—PTGS1—cardiac atrium—lung cancer	0.000297	0.0152	CbGeAlD
Rosiglitazone—PPARG—lymph node—lung cancer	0.00029	0.0148	CbGeAlD
Rosiglitazone—ALB—lymph node—lung cancer	0.000272	0.0139	CbGeAlD
Rosiglitazone—CYP1A2—lung—lung cancer	0.000262	0.0134	CbGeAlD
Rosiglitazone—PTGS1—lung—lung cancer	0.000227	0.0116	CbGeAlD
Rosiglitazone—Eye disorder—Etoposide—lung cancer	0.000175	0.00135	CcSEcCtD
Rosiglitazone—Cardiac disorder—Etoposide—lung cancer	0.000174	0.00134	CcSEcCtD
Rosiglitazone—Erythema multiforme—Paclitaxel—lung cancer	0.000174	0.00134	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—lung cancer	0.000173	0.00133	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000172	0.00133	CcSEcCtD
Rosiglitazone—Eye disorder—Paclitaxel—lung cancer	0.000172	0.00133	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Docetaxel—lung cancer	0.000171	0.00132	CcSEcCtD
Rosiglitazone—Leukopenia—Gemcitabine—lung cancer	0.000171	0.00132	CcSEcCtD
Rosiglitazone—Cardiac disorder—Paclitaxel—lung cancer	0.000171	0.00132	CcSEcCtD
Rosiglitazone—Myocardial infarction—Docetaxel—lung cancer	0.00017	0.00131	CcSEcCtD
Rosiglitazone—Hypertension—Irinotecan—lung cancer	0.00017	0.00131	CcSEcCtD
Rosiglitazone—Immune system disorder—Etoposide—lung cancer	0.00017	0.00131	CcSEcCtD
Rosiglitazone—Asthenia—Vinblastine—lung cancer	0.000168	0.0013	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000168	0.00129	CcSEcCtD
Rosiglitazone—Fatigue—Vinorelbine—lung cancer	0.000168	0.00129	CcSEcCtD
Rosiglitazone—Constipation—Vinorelbine—lung cancer	0.000166	0.00128	CcSEcCtD
Rosiglitazone—Immune system disorder—Paclitaxel—lung cancer	0.000166	0.00128	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—lung cancer	0.000166	0.00128	CcSEcCtD
Rosiglitazone—Hypertension—Gemcitabine—lung cancer	0.000165	0.00127	CcSEcCtD
Rosiglitazone—Anaemia—Cisplatin—lung cancer	0.000165	0.00127	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Docetaxel—lung cancer	0.000164	0.00127	CcSEcCtD
Rosiglitazone—Asthenia—Topotecan—lung cancer	0.000163	0.00126	CcSEcCtD
Rosiglitazone—Arthralgia—Gemcitabine—lung cancer	0.000163	0.00126	CcSEcCtD
Rosiglitazone—Myalgia—Gemcitabine—lung cancer	0.000163	0.00126	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—lung cancer	0.000162	0.00125	CcSEcCtD
Rosiglitazone—Asthenia—Erlotinib—lung cancer	0.000161	0.00124	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—lung cancer	0.000161	0.00124	CcSEcCtD
Rosiglitazone—Pruritus—Topotecan—lung cancer	0.000161	0.00124	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Irinotecan—lung cancer	0.00016	0.00124	CcSEcCtD
Rosiglitazone—Oedema—Irinotecan—lung cancer	0.00016	0.00124	CcSEcCtD
Rosiglitazone—Malnutrition—Paclitaxel—lung cancer	0.00016	0.00124	CcSEcCtD
Rosiglitazone—Diarrhoea—Vinblastine—lung cancer	0.00016	0.00123	CcSEcCtD
Rosiglitazone—Leukopenia—Cisplatin—lung cancer	0.00016	0.00123	CcSEcCtD
Rosiglitazone—Infection—Irinotecan—lung cancer	0.000159	0.00123	CcSEcCtD
Rosiglitazone—Pruritus—Erlotinib—lung cancer	0.000159	0.00123	CcSEcCtD
Rosiglitazone—Back pain—Etoposide—lung cancer	0.000158	0.00122	CcSEcCtD
Rosiglitazone—Nervous system disorder—Irinotecan—lung cancer	0.000157	0.00121	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Irinotecan—lung cancer	0.000157	0.00121	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—lung cancer	0.000157	0.00121	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Gemcitabine—lung cancer	0.000156	0.00121	CcSEcCtD
Rosiglitazone—Oedema—Gemcitabine—lung cancer	0.000156	0.00121	CcSEcCtD
Rosiglitazone—Hepatitis—Docetaxel—lung cancer	0.000156	0.0012	CcSEcCtD
Rosiglitazone—Diarrhoea—Topotecan—lung cancer	0.000156	0.0012	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—lung cancer	0.000155	0.0012	CcSEcCtD
Rosiglitazone—Infection—Gemcitabine—lung cancer	0.000155	0.0012	CcSEcCtD
Rosiglitazone—PTGS1—lymph node—lung cancer	0.000155	0.00793	CbGeAlD
Rosiglitazone—Back pain—Paclitaxel—lung cancer	0.000155	0.0012	CcSEcCtD
Rosiglitazone—Dizziness—Vinblastine—lung cancer	0.000155	0.00119	CcSEcCtD
Rosiglitazone—Urticaria—Vinorelbine—lung cancer	0.000154	0.00119	CcSEcCtD
Rosiglitazone—Diarrhoea—Erlotinib—lung cancer	0.000154	0.00119	CcSEcCtD
Rosiglitazone—Oedema peripheral—Docetaxel—lung cancer	0.000154	0.00119	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Docetaxel—lung cancer	0.000153	0.00118	CcSEcCtD
Rosiglitazone—Nervous system disorder—Gemcitabine—lung cancer	0.000153	0.00118	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Gemcitabine—lung cancer	0.000153	0.00118	CcSEcCtD
Rosiglitazone—Myalgia—Cisplatin—lung cancer	0.000152	0.00117	CcSEcCtD
Rosiglitazone—Anaemia—Etoposide—lung cancer	0.000151	0.00117	CcSEcCtD
Rosiglitazone—Dizziness—Topotecan—lung cancer	0.00015	0.00116	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—lung cancer	0.00015	0.00116	CcSEcCtD
Rosiglitazone—Dizziness—Erlotinib—lung cancer	0.000149	0.00115	CcSEcCtD
Rosiglitazone—Anaemia—Paclitaxel—lung cancer	0.000148	0.00114	CcSEcCtD
Rosiglitazone—Erythema multiforme—Docetaxel—lung cancer	0.000148	0.00114	CcSEcCtD
Rosiglitazone—Headache—Vinblastine—lung cancer	0.000147	0.00113	CcSEcCtD
Rosiglitazone—Angioedema—Paclitaxel—lung cancer	0.000146	0.00113	CcSEcCtD
Rosiglitazone—Leukopenia—Etoposide—lung cancer	0.000146	0.00113	CcSEcCtD
Rosiglitazone—Eye disorder—Docetaxel—lung cancer	0.000146	0.00112	CcSEcCtD
Rosiglitazone—Oedema—Cisplatin—lung cancer	0.000146	0.00112	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Cisplatin—lung cancer	0.000146	0.00112	CcSEcCtD
Rosiglitazone—Cardiac disorder—Docetaxel—lung cancer	0.000145	0.00112	CcSEcCtD
Rosiglitazone—Infection—Cisplatin—lung cancer	0.000145	0.00112	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Doxorubicin—lung cancer	0.000144	0.00111	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—lung cancer	0.000144	0.00111	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—lung cancer	0.000144	0.00111	CcSEcCtD
Rosiglitazone—Leukopenia—Paclitaxel—lung cancer	0.000143	0.00111	CcSEcCtD
Rosiglitazone—Rash—Topotecan—lung cancer	0.000143	0.00111	CcSEcCtD
Rosiglitazone—Dermatitis—Topotecan—lung cancer	0.000143	0.0011	CcSEcCtD
Rosiglitazone—Nervous system disorder—Cisplatin—lung cancer	0.000143	0.0011	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Cisplatin—lung cancer	0.000143	0.0011	CcSEcCtD
Rosiglitazone—Headache—Topotecan—lung cancer	0.000142	0.0011	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000142	0.0011	CcSEcCtD
Rosiglitazone—Rash—Erlotinib—lung cancer	0.000142	0.00109	CcSEcCtD
Rosiglitazone—Dermatitis—Erlotinib—lung cancer	0.000142	0.00109	CcSEcCtD
Rosiglitazone—Hypertension—Etoposide—lung cancer	0.000141	0.00109	CcSEcCtD
Rosiglitazone—Immune system disorder—Docetaxel—lung cancer	0.000141	0.00109	CcSEcCtD
Rosiglitazone—Headache—Erlotinib—lung cancer	0.000141	0.00109	CcSEcCtD
Rosiglitazone—Asthenia—Vinorelbine—lung cancer	0.00014	0.00108	CcSEcCtD
Rosiglitazone—Nausea—Vinblastine—lung cancer	0.000139	0.00107	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000138	0.00107	CcSEcCtD
Rosiglitazone—Hypertension—Paclitaxel—lung cancer	0.000138	0.00107	CcSEcCtD
Rosiglitazone—Fatigue—Irinotecan—lung cancer	0.000138	0.00107	CcSEcCtD
Rosiglitazone—Pruritus—Vinorelbine—lung cancer	0.000138	0.00106	CcSEcCtD
Rosiglitazone—Constipation—Irinotecan—lung cancer	0.000137	0.00106	CcSEcCtD
Rosiglitazone—Arthralgia—Paclitaxel—lung cancer	0.000136	0.00105	CcSEcCtD
Rosiglitazone—Myalgia—Paclitaxel—lung cancer	0.000136	0.00105	CcSEcCtD
Rosiglitazone—Malnutrition—Docetaxel—lung cancer	0.000136	0.00105	CcSEcCtD
Rosiglitazone—Nausea—Topotecan—lung cancer	0.000135	0.00104	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000135	0.00104	CcSEcCtD
Rosiglitazone—Fatigue—Gemcitabine—lung cancer	0.000135	0.00104	CcSEcCtD
Rosiglitazone—Constipation—Gemcitabine—lung cancer	0.000134	0.00103	CcSEcCtD
Rosiglitazone—Nausea—Erlotinib—lung cancer	0.000134	0.00103	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Etoposide—lung cancer	0.000133	0.00103	CcSEcCtD
Rosiglitazone—Diarrhoea—Vinorelbine—lung cancer	0.000133	0.00103	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000133	0.00102	CcSEcCtD
Rosiglitazone—Infection—Etoposide—lung cancer	0.000133	0.00102	CcSEcCtD
Rosiglitazone—Back pain—Docetaxel—lung cancer	0.000131	0.00101	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Paclitaxel—lung cancer	0.000131	0.00101	CcSEcCtD
Rosiglitazone—Oedema—Paclitaxel—lung cancer	0.000131	0.00101	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Etoposide—lung cancer	0.000131	0.00101	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—lung cancer	0.000131	0.00101	CcSEcCtD
Rosiglitazone—Infection—Paclitaxel—lung cancer	0.00013	0.001	CcSEcCtD
Rosiglitazone—Dizziness—Vinorelbine—lung cancer	0.000129	0.000992	CcSEcCtD
Rosiglitazone—Nervous system disorder—Paclitaxel—lung cancer	0.000128	0.000989	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Paclitaxel—lung cancer	0.000128	0.000988	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—lung cancer	0.000126	0.000971	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000126	0.00097	CcSEcCtD
Rosiglitazone—Anaemia—Docetaxel—lung cancer	0.000126	0.000968	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000124	0.000958	CcSEcCtD
Rosiglitazone—Rash—Vinorelbine—lung cancer	0.000123	0.000946	CcSEcCtD
Rosiglitazone—Dermatitis—Vinorelbine—lung cancer	0.000122	0.000945	CcSEcCtD
Rosiglitazone—Headache—Vinorelbine—lung cancer	0.000122	0.00094	CcSEcCtD
Rosiglitazone—Leukopenia—Docetaxel—lung cancer	0.000122	0.000938	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000119	0.000919	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—lung cancer	0.000118	0.000914	CcSEcCtD
Rosiglitazone—Hypertension—Docetaxel—lung cancer	0.000117	0.000905	CcSEcCtD
Rosiglitazone—Arthralgia—Docetaxel—lung cancer	0.000116	0.000892	CcSEcCtD
Rosiglitazone—Myalgia—Docetaxel—lung cancer	0.000116	0.000892	CcSEcCtD
Rosiglitazone—Nausea—Vinorelbine—lung cancer	0.000115	0.000891	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Etoposide—lung cancer	0.000115	0.000888	CcSEcCtD
Rosiglitazone—Asthenia—Irinotecan—lung cancer	0.000115	0.000888	CcSEcCtD
Rosiglitazone—Fatigue—Etoposide—lung cancer	0.000115	0.000887	CcSEcCtD
Rosiglitazone—Constipation—Etoposide—lung cancer	0.000114	0.00088	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000113	0.000872	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000113	0.000871	CcSEcCtD
Rosiglitazone—Fatigue—Paclitaxel—lung cancer	0.000113	0.00087	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—lung cancer	0.000112	0.000868	CcSEcCtD
Rosiglitazone—Asthenia—Gemcitabine—lung cancer	0.000112	0.000865	CcSEcCtD
Rosiglitazone—Constipation—Paclitaxel—lung cancer	0.000112	0.000863	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Docetaxel—lung cancer	0.000111	0.000855	CcSEcCtD
Rosiglitazone—Oedema—Docetaxel—lung cancer	0.000111	0.000855	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—lung cancer	0.000111	0.000854	CcSEcCtD
Rosiglitazone—Pruritus—Gemcitabine—lung cancer	0.000111	0.000853	CcSEcCtD
Rosiglitazone—Infection—Docetaxel—lung cancer	0.00011	0.00085	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—lung cancer	0.00011	0.000847	CcSEcCtD
Rosiglitazone—Diarrhoea—Irinotecan—lung cancer	0.00011	0.000846	CcSEcCtD
Rosiglitazone—Nervous system disorder—Docetaxel—lung cancer	0.000109	0.000839	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Docetaxel—lung cancer	0.000109	0.000837	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000108	0.00083	CcSEcCtD
Rosiglitazone—Diarrhoea—Gemcitabine—lung cancer	0.000107	0.000825	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—lung cancer	0.000106	0.00082	CcSEcCtD
Rosiglitazone—Dizziness—Irinotecan—lung cancer	0.000106	0.000818	CcSEcCtD
Rosiglitazone—Urticaria—Etoposide—lung cancer	0.000106	0.000817	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—lung cancer	0.000105	0.000811	CcSEcCtD
Rosiglitazone—Asthenia—Cisplatin—lung cancer	0.000104	0.000806	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—lung cancer	0.000104	0.000805	CcSEcCtD
Rosiglitazone—Urticaria—Paclitaxel—lung cancer	0.000104	0.000802	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—lung cancer	0.000103	0.000791	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—lung cancer	0.000102	0.000785	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—lung cancer	0.000102	0.000784	CcSEcCtD
Rosiglitazone—Rash—Irinotecan—lung cancer	0.000101	0.00078	CcSEcCtD
Rosiglitazone—Dermatitis—Irinotecan—lung cancer	0.000101	0.000779	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000101	0.000779	CcSEcCtD
Rosiglitazone—Headache—Irinotecan—lung cancer	0.0001	0.000775	CcSEcCtD
Rosiglitazone—Diarrhoea—Cisplatin—lung cancer	9.96e-05	0.000769	CcSEcCtD
Rosiglitazone—Rash—Gemcitabine—lung cancer	9.85e-05	0.00076	CcSEcCtD
Rosiglitazone—Dermatitis—Gemcitabine—lung cancer	9.84e-05	0.000759	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—lung cancer	9.79e-05	0.000755	CcSEcCtD
Rosiglitazone—Headache—Gemcitabine—lung cancer	9.79e-05	0.000755	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—lung cancer	9.74e-05	0.000751	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—lung cancer	9.59e-05	0.00074	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Docetaxel—lung cancer	9.57e-05	0.000738	CcSEcCtD
Rosiglitazone—Asthenia—Etoposide—lung cancer	9.57e-05	0.000738	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—lung cancer	9.57e-05	0.000738	CcSEcCtD
Rosiglitazone—Fatigue—Docetaxel—lung cancer	9.56e-05	0.000737	CcSEcCtD
Rosiglitazone—Nausea—Irinotecan—lung cancer	9.52e-05	0.000735	CcSEcCtD
Rosiglitazone—Constipation—Docetaxel—lung cancer	9.48e-05	0.000731	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—lung cancer	9.47e-05	0.000731	CcSEcCtD
Rosiglitazone—Pruritus—Etoposide—lung cancer	9.44e-05	0.000728	CcSEcCtD
Rosiglitazone—Asthenia—Paclitaxel—lung cancer	9.38e-05	0.000724	CcSEcCtD
Rosiglitazone—Nausea—Gemcitabine—lung cancer	9.28e-05	0.000716	CcSEcCtD
Rosiglitazone—Pruritus—Paclitaxel—lung cancer	9.25e-05	0.000714	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—lung cancer	9.21e-05	0.00071	CcSEcCtD
Rosiglitazone—Rash—Cisplatin—lung cancer	9.18e-05	0.000708	CcSEcCtD
Rosiglitazone—Dermatitis—Cisplatin—lung cancer	9.17e-05	0.000708	CcSEcCtD
Rosiglitazone—Diarrhoea—Etoposide—lung cancer	9.13e-05	0.000704	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—lung cancer	9.1e-05	0.000702	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—lung cancer	9.05e-05	0.000698	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—lung cancer	9.04e-05	0.000697	CcSEcCtD
Rosiglitazone—Diarrhoea—Paclitaxel—lung cancer	8.95e-05	0.00069	CcSEcCtD
Rosiglitazone—Dizziness—Etoposide—lung cancer	8.82e-05	0.00068	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—lung cancer	8.8e-05	0.000679	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—lung cancer	8.76e-05	0.000676	CcSEcCtD
Rosiglitazone—Dizziness—Paclitaxel—lung cancer	8.65e-05	0.000667	CcSEcCtD
Rosiglitazone—Nausea—Cisplatin—lung cancer	8.65e-05	0.000667	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—lung cancer	8.48e-05	0.000654	CcSEcCtD
Rosiglitazone—Rash—Etoposide—lung cancer	8.41e-05	0.000649	CcSEcCtD
Rosiglitazone—Dermatitis—Etoposide—lung cancer	8.4e-05	0.000648	CcSEcCtD
Rosiglitazone—Headache—Etoposide—lung cancer	8.36e-05	0.000645	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—lung cancer	8.33e-05	0.000643	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—lung cancer	8.33e-05	0.000643	CcSEcCtD
Rosiglitazone—Rash—Paclitaxel—lung cancer	8.25e-05	0.000636	CcSEcCtD
Rosiglitazone—Dermatitis—Paclitaxel—lung cancer	8.24e-05	0.000636	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—lung cancer	8.2e-05	0.000633	CcSEcCtD
Rosiglitazone—Headache—Paclitaxel—lung cancer	8.19e-05	0.000632	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—lung cancer	7.99e-05	0.000616	CcSEcCtD
Rosiglitazone—Asthenia—Docetaxel—lung cancer	7.95e-05	0.000614	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—lung cancer	7.94e-05	0.000612	CcSEcCtD
Rosiglitazone—Nausea—Etoposide—lung cancer	7.92e-05	0.000611	CcSEcCtD
Rosiglitazone—Pruritus—Docetaxel—lung cancer	7.84e-05	0.000605	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—lung cancer	7.84e-05	0.000604	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—lung cancer	7.83e-05	0.000604	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—lung cancer	7.82e-05	0.000603	CcSEcCtD
Rosiglitazone—Nausea—Paclitaxel—lung cancer	7.77e-05	0.000599	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—lung cancer	7.59e-05	0.000585	CcSEcCtD
Rosiglitazone—Diarrhoea—Docetaxel—lung cancer	7.58e-05	0.000585	CcSEcCtD
Rosiglitazone—Dizziness—Docetaxel—lung cancer	7.33e-05	0.000566	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—lung cancer	7.32e-05	0.000565	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—lung cancer	7.28e-05	0.000562	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—lung cancer	7.22e-05	0.000557	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—lung cancer	7.22e-05	0.000557	CcSEcCtD
Rosiglitazone—Rash—Docetaxel—lung cancer	6.99e-05	0.000539	CcSEcCtD
Rosiglitazone—Dermatitis—Docetaxel—lung cancer	6.98e-05	0.000539	CcSEcCtD
Rosiglitazone—Headache—Docetaxel—lung cancer	6.94e-05	0.000536	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—lung cancer	6.92e-05	0.000534	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—lung cancer	6.92e-05	0.000534	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—lung cancer	6.9e-05	0.000532	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—lung cancer	6.89e-05	0.000531	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—lung cancer	6.87e-05	0.00053	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—lung cancer	6.78e-05	0.000523	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—lung cancer	6.77e-05	0.000523	CcSEcCtD
Rosiglitazone—Nausea—Docetaxel—lung cancer	6.58e-05	0.000508	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—lung cancer	6.35e-05	0.00049	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.3e-05	0.000486	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—lung cancer	5.97e-05	0.000461	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—lung cancer	5.96e-05	0.00046	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—lung cancer	5.92e-05	0.000456	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—lung cancer	5.73e-05	0.000442	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—lung cancer	5.65e-05	0.000436	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—lung cancer	5.5e-05	0.000424	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—lung cancer	5.47e-05	0.000422	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—lung cancer	5.28e-05	0.000408	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—lung cancer	5.04e-05	0.000389	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—lung cancer	5.03e-05	0.000388	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—lung cancer	5.01e-05	0.000386	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—lung cancer	4.96e-05	0.000383	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—lung cancer	4.89e-05	0.000378	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—lung cancer	4.75e-05	0.000366	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—lung cancer	4.73e-05	0.000365	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—lung cancer	4.57e-05	0.000353	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—lung cancer	4.36e-05	0.000337	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—lung cancer	4.36e-05	0.000336	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—lung cancer	4.33e-05	0.000334	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—lung cancer	4.11e-05	0.000317	CcSEcCtD
Rosiglitazone—CYP2D6—Metabolism—PPP2R1B—lung cancer	6.42e-06	6.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP2E1—lung cancer	6.41e-06	6.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ENO2—lung cancer	6.4e-06	6.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HPGDS—lung cancer	6.4e-06	6.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ENO1—lung cancer	6.38e-06	6.79e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP2E1—lung cancer	6.37e-06	6.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPP2R1B—lung cancer	6.36e-06	6.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.36e-06	6.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NQO1—lung cancer	6.34e-06	6.75e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NQO1—lung cancer	6.3e-06	6.71e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CG—lung cancer	6.28e-06	6.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.28e-06	6.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.28e-06	6.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—lung cancer	6.26e-06	6.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2—lung cancer	6.23e-06	6.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—lung cancer	6.21e-06	6.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.21e-06	6.61e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNG11—lung cancer	6.2e-06	6.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2A6—lung cancer	6.19e-06	6.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCLC—lung cancer	6.19e-06	6.59e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.17e-06	6.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.17e-06	6.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.15e-06	6.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCLC—lung cancer	6.14e-06	6.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2A6—lung cancer	6.14e-06	6.53e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOA1—lung cancer	6.12e-06	6.51e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.12e-06	6.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.11e-06	6.5e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CB—lung cancer	6.11e-06	6.5e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—lung cancer	6.05e-06	6.44e-05	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	6.01e-06	6.4e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—lung cancer	5.98e-06	6.36e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDOA—lung cancer	5.91e-06	6.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ENO1—lung cancer	5.87e-06	6.24e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.86e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CREBBP—lung cancer	5.82e-06	6.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ENO1—lung cancer	5.82e-06	6.19e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MAPK3—lung cancer	5.8e-06	6.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.8e-06	6.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOA1—lung cancer	5.79e-06	6.16e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOA3—lung cancer	5.73e-06	6.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2E1—lung cancer	5.72e-06	6.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.72e-06	6.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—STK11—lung cancer	5.71e-06	6.08e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—STK11—lung cancer	5.68e-06	6.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NQO1—lung cancer	5.66e-06	6.02e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—lung cancer	5.64e-06	6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.63e-06	6e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—EP300—lung cancer	5.59e-06	5.94e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—lung cancer	5.59e-06	5.94e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADCY1—lung cancer	5.58e-06	5.93e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCG2—lung cancer	5.58e-06	5.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.54e-06	5.9e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CD—lung cancer	5.52e-06	5.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.49e-06	5.84e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO2—lung cancer	5.47e-06	5.82e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HPGDS—lung cancer	5.47e-06	5.82e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—lung cancer	5.45e-06	5.8e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPP2R1B—lung cancer	5.44e-06	5.78e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SRC—lung cancer	5.43e-06	5.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.36e-06	5.71e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.36e-06	5.71e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.33e-06	5.68e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—lung cancer	5.32e-06	5.66e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—lung cancer	5.3e-06	5.65e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—lung cancer	5.29e-06	5.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—lung cancer	5.29e-06	5.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—lung cancer	5.28e-06	5.62e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—lung cancer	5.28e-06	5.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2E1—lung cancer	5.26e-06	5.6e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—lung cancer	5.26e-06	5.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2A6—lung cancer	5.24e-06	5.58e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCLC—lung cancer	5.24e-06	5.58e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NRAS—lung cancer	5.23e-06	5.56e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.22e-06	5.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2E1—lung cancer	5.22e-06	5.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NQO1—lung cancer	5.2e-06	5.54e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CREBBP—lung cancer	5.18e-06	5.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NQO1—lung cancer	5.16e-06	5.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAT—lung cancer	5.14e-06	5.47e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAT—lung cancer	5.12e-06	5.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.12e-06	5.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—STK11—lung cancer	5.1e-06	5.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.09e-06	5.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.05e-06	5.38e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—EP300—lung cancer	5.03e-06	5.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—lung cancer	5.03e-06	5.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.01e-06	5.33e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK3—lung cancer	5.01e-06	5.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—lung cancer	5e-06	5.33e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—lung cancer	4.98e-06	5.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO1—lung cancer	4.97e-06	5.29e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.95e-06	5.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TYMS—lung cancer	4.92e-06	5.23e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—lung cancer	4.91e-06	5.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CREBBP—lung cancer	4.9e-06	5.21e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.89e-06	5.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TYMS—lung cancer	4.89e-06	5.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—lung cancer	4.86e-06	5.17e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—lung cancer	4.85e-06	5.16e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—lung cancer	4.83e-06	5.14e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—lung cancer	4.81e-06	5.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.79e-06	5.09e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—lung cancer	4.77e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—lung cancer	4.72e-06	5.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—STK11—lung cancer	4.69e-06	4.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—STK11—lung cancer	4.65e-06	4.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—lung cancer	4.64e-06	4.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1A1—lung cancer	4.61e-06	4.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAT—lung cancer	4.59e-06	4.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—lung cancer	4.58e-06	4.88e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1A1—lung cancer	4.58e-06	4.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ERCC2—lung cancer	4.57e-06	4.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.57e-06	4.86e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ERCC2—lung cancer	4.54e-06	4.83e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—lung cancer	4.5e-06	4.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—lung cancer	4.47e-06	4.75e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2E1—lung cancer	4.46e-06	4.74e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NQO1—lung cancer	4.41e-06	4.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TYMS—lung cancer	4.39e-06	4.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.37e-06	4.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—lung cancer	4.34e-06	4.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—lung cancer	4.34e-06	4.61e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.32e-06	4.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—lung cancer	4.3e-06	4.58e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—lung cancer	4.28e-06	4.55e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.28e-06	4.55e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—lung cancer	4.24e-06	4.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAT—lung cancer	4.22e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAT—lung cancer	4.19e-06	4.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.16e-06	4.43e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—lung cancer	4.16e-06	4.42e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—lung cancer	4.13e-06	4.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1A1—lung cancer	4.11e-06	4.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—lung cancer	4.11e-06	4.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ERCC2—lung cancer	4.08e-06	4.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—lung cancer	4.07e-06	4.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—lung cancer	4.05e-06	4.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMS—lung cancer	4.04e-06	4.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—lung cancer	4.01e-06	4.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMS—lung cancer	4e-06	4.26e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—lung cancer	4e-06	4.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—lung cancer	3.99e-06	4.24e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—STK11—lung cancer	3.97e-06	4.23e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—EP300—lung cancer	3.96e-06	4.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—lung cancer	3.95e-06	4.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOA1—lung cancer	3.95e-06	4.21e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOA1—lung cancer	3.93e-06	4.18e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—lung cancer	3.91e-06	4.16e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—lung cancer	3.82e-06	4.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.78e-06	4.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1A1—lung cancer	3.78e-06	4.02e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.76e-06	4e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ERCC2—lung cancer	3.75e-06	3.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1A1—lung cancer	3.75e-06	3.99e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.73e-06	3.97e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—lung cancer	3.72e-06	3.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ERCC2—lung cancer	3.72e-06	3.96e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—lung cancer	3.7e-06	3.94e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—lung cancer	3.68e-06	3.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—lung cancer	3.61e-06	3.84e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—lung cancer	3.59e-06	3.82e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAT—lung cancer	3.58e-06	3.81e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.56e-06	3.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOA1—lung cancer	3.53e-06	3.75e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—EP300—lung cancer	3.53e-06	3.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—lung cancer	3.5e-06	3.72e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—lung cancer	3.48e-06	3.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—lung cancer	3.43e-06	3.65e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMS—lung cancer	3.42e-06	3.64e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—lung cancer	3.41e-06	3.63e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—lung cancer	3.38e-06	3.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.38e-06	3.59e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—lung cancer	3.38e-06	3.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CREBBP—lung cancer	3.34e-06	3.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—EP300—lung cancer	3.34e-06	3.55e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CREBBP—lung cancer	3.33e-06	3.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA1—lung cancer	3.24e-06	3.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—lung cancer	3.22e-06	3.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA1—lung cancer	3.22e-06	3.42e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1A1—lung cancer	3.2e-06	3.41e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ERCC2—lung cancer	3.18e-06	3.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—lung cancer	3.17e-06	3.37e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—lung cancer	3.15e-06	3.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—lung cancer	3.13e-06	3.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.08e-06	3.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—lung cancer	3.07e-06	3.26e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—lung cancer	3.04e-06	3.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CREBBP—lung cancer	2.99e-06	3.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—lung cancer	2.96e-06	3.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—lung cancer	2.94e-06	3.12e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—lung cancer	2.93e-06	3.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—lung cancer	2.83e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—lung cancer	2.82e-06	3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—lung cancer	2.79e-06	2.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—lung cancer	2.79e-06	2.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—lung cancer	2.76e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—lung cancer	2.75e-06	2.92e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA1—lung cancer	2.75e-06	2.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CREBBP—lung cancer	2.75e-06	2.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—lung cancer	2.74e-06	2.91e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—lung cancer	2.72e-06	2.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CREBBP—lung cancer	2.72e-06	2.9e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.63e-06	2.8e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—lung cancer	2.61e-06	2.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—lung cancer	2.6e-06	2.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—lung cancer	2.58e-06	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—lung cancer	2.57e-06	2.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—lung cancer	2.55e-06	2.71e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—lung cancer	2.51e-06	2.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—lung cancer	2.47e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—lung cancer	2.47e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—lung cancer	2.44e-06	2.6e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—lung cancer	2.4e-06	2.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—lung cancer	2.39e-06	2.54e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—lung cancer	2.39e-06	2.54e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—lung cancer	2.38e-06	2.53e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CREBBP—lung cancer	2.33e-06	2.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—EP300—lung cancer	2.28e-06	2.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—lung cancer	2.27e-06	2.41e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—EP300—lung cancer	2.27e-06	2.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—lung cancer	2.25e-06	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—lung cancer	2.25e-06	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—lung cancer	2.23e-06	2.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—lung cancer	2.21e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—lung cancer	2.18e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—lung cancer	2.13e-06	2.27e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—lung cancer	2.13e-06	2.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—EP300—lung cancer	2.03e-06	2.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—lung cancer	2.02e-06	2.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—lung cancer	1.96e-06	2.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—lung cancer	1.94e-06	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—lung cancer	1.92e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—lung cancer	1.9e-06	2.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—EP300—lung cancer	1.87e-06	1.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—EP300—lung cancer	1.85e-06	1.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—lung cancer	1.69e-06	1.79e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—lung cancer	1.68e-06	1.78e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—lung cancer	1.66e-06	1.77e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—EP300—lung cancer	1.58e-06	1.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—lung cancer	1.5e-06	1.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.38e-06	1.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—lung cancer	1.38e-06	1.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—lung cancer	1.37e-06	1.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—lung cancer	1.37e-06	1.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—lung cancer	1.23e-06	1.31e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—lung cancer	1.17e-06	1.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—lung cancer	1.13e-06	1.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—lung cancer	1.12e-06	1.19e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—lung cancer	9.57e-07	1.02e-05	CbGpPWpGaD
